Imidazopyridazines useful as inhibitors of the PAR-2 signaling pathway

The present invention relates to compounds useful as inhibitors of the PAR-2 signaling pathway. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of...

Full description

Saved in:
Bibliographic Details
Main Authors Sturino, Claudio, Szychowski, Janek, Vallee, Frederic, Fournier, Pierre-Andre, Sayegh, Camil Elie, Bubenik, Monica, Martel, Julien, Yannopoulos, Constantin, Lacoste, Jean-Eric, St-Onge, Miguel, Farmer, Luc J, Liu, Bingcan, Ramtohul, Yeeman, Lessard, Stephanie
Format Patent
LanguageEnglish
Published 13.12.2018
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to compounds useful as inhibitors of the PAR-2 signaling pathway. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating of various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in
Bibliography:Application Number: AU20140326596